Acorda Therapeutics, Inc. Shareholders' Equity
Acorda Therapeutics, Inc. had Shareholders' Equity of -$185.77 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-05-14
- 2024-03-31: Stockholders' Equity Attributable to Parent -$185.77M.
- 2023-12-31: Stockholders' Equity Attributable to Parent -$157.96M.
- 2023-09-30: Stockholders' Equity Attributable to Parent $58.96M.
- 2023-06-30: Stockholders' Equity Attributable to Parent $67.87M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2024-03-31 | -$185.77M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | -$157.96M 10-Q · filed 2024-05-14 | |
| 2023-09-30 | $58.96M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $67.87M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $76.96M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $93.62M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $75.77M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $87.91M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $127.55M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $151.14M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $164.47M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $190.48M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $206.28M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $237.96M 10-K · filed 2022-03-18 | |
| 2020-09-30 | $313.53M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $290.90M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $306.67M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $310.82M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $281.34M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $544.84M 10-Q · filed 2019-11-07 | |
| 2019-03-31 | $566.59M 10-Q · filed 2019-11-07 | |
| 2018-12-31 | $611.98M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $598.63M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $606.63M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | $549.92M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $519.99M 10-Q · filed 2019-11-07 | |
| 2016-09-30 | $666.77M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $671.64M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $684.01M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $603.02M 10-Q · filed 2016-11-07 | |
| 2015-09-30 | $574.89M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $560.28M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $549.02M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $540.25M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $522.91M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $500.38M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $450.52M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $440.35M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $426.39M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $404.80M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $391.64M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $385.92M 10-K · filed 2016-02-29 | |
| 2012-09-30 | $245.47M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $229.65M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $219.09M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $205.21M 10-K · filed 2015-02-27 | |
| 2011-09-30 | $186.92M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $162.75M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $154.79M 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $151.26M 10-K · filed 2014-03-03 | $151.26M 10-K · filed 2011-03-01 |
| 2010-09-30 | $142.36M 10-Q · filed 2010-11-09 | |
| 2010-06-30 | $122.70M 10-Q · filed 2010-08-09 | |
| 2009-12-31 | $137.33M 10-K · filed 2013-02-28 | $137.33M 10-Q · filed 2010-08-09 |
| 2008-12-31 | $207.16M 10-K · filed 2012-02-28 | $207.16M 10-K · filed 2011-03-01 |
| 2007-12-31 | $63.43M 10-K · filed 2011-03-01 |